| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $119.60 | $23.64 | 405.88% | 225.66x | 56.92x | 15.17x | 18.32x | 1.64x | $106.92M | 0.85% | $705.78M | 6.70 | $12.83B | 1,635.05 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $24.17 | $8.08 | 199.25% | 115.10x | 54.04x | 6.80x | 13.77x | 0.99x | $39.15M | 1.24% | $220.58M | 1.69 | $3.12B | 68.68 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $224.41 | $79.13 | 183.58% | 36.79x | 33.28x | 6.24x | 22.18x | 1.27x | $793.95M | 2.65% | $1.35B | 10.14 | $31.31B | 26.55 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $77.96 | $17.03 | 357.71% | 72.86x | 66.70x | 7.19x | 9.30x | 1.86x | $182.84M | 3.02% | $654.15M | 8.43 | $5.92B | 49.32 | ||
| RPRX | ROYALTY PHARMA PLC | $56.76 | $35.58 | 59.53% | 30.19x | 10.38x | 9.96x | 3.34x | 0.61x | $2.92B | 11.57% | $9.79B | 21.99 | $40.79B | 34.68 | ||
| KRYS | KRYSTAL BIOTECH INC | $324.57 | $82.57 | 293.08% | 39.25x | 41.58x | 21.76x | 7.07x | 2.10x | $257.78M | 2.69% | $1.36B | 46.03 | $9.19B | 39.39 | ||
| HALO | HALOZYME THERAPEUTICS INC | $110.79 | $69.98 | 58.32% | 31.12x | 12.27x | 7.81x | 87.60x | 0.60x | $806.22M | 6.21% | $143.54M | 1.22 | $14.56B | 20.26 | ||
| VCEL | VERICEL CORP | $40.74 | $7.86 | 418.16% | 84.88x | 72.79x | 6.79x | 5.64x | 2.08x | $61.66M | 2.96% | $370.04M | 7.25 | $2.05B | 46.62 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.08 | $7.48 | 48.03% | 11.66x | 10.18x | 4.82x | 3.02x | 1.02x | $82.01M | 12.51% | $217.65M | 3.68 | $514.15M | 6.65 | ||
| TGTX | TG THERAPEUTICS INC | $52.95 | $22.05 | 140.16% | 17.19x | 53.28x | 9.39x | 13.42x | 1.91x | $17.39M | 0.23% | $604.08M | 4.26 | $8.37B | 60.15 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.20 | $18.33 | 201.21% | 145.26x | 19.08x | 3.13x | 1.69x | 0.97x | $738.18M | 6.91% | $6.32B | 32.68 | $14.00B | 36.29 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $231.19 | $177.29 | 30.40% | 15.15x | 9.05x | 3.18x | 3.13x | 0.62x | $1.62B | 11.08% | $4.80B | 75.98 | $17.78B | 11.00 | ||
| EXEL | EXELIXIS INC | $58.44 | $29.51 | 98.04% | 17.76x | 17.67x | 6.02x | 7.85x | 1.17x | $1.17B | 8.00% | $1.84B | 7.35 | $14.36B | 13.21 | ||
| MDXG | MIMEDX GROUP INC | $4.61 | $1.25 | 268.19% | 115.25x | -26.59x | 1.92x | 3.11x | 1.25x | $44.50M | 6.53% | $216.00M | 1.46 | $553.32M | 24.26 | ||
| ADMA | ADMA BIOLOGICS INC | $10.14 | $6.86 | 47.76% | 14.08x | 12.75x | 4.52x | 5.56x | 0.82x | $116.47M | 5.03% | $408.21M | 1.79 | $2.33B | 10.01 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $293.26 | $84.43 | 247.34% | 29.12x | 31.04x | 20.25x | 6.04x | 2.21x | $130.62M | 2.22% | $967.52M | 48.22 | $5.97B | 21.40 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $505.64 | $145.91 | 246.54% | 29.18x | 26.41x | 10.19x | 6.33x | 2.19x | $3.80B | 2.96% | $20.25B | 79.81 | $123.99B | 22.53 | ||
| UTHR | UNITED THERAPEUTICS CORP | $545.00 | $185.50 | 193.80% | 18.02x | 20.39x | 7.36x | 3.65x | 3.31x | $1.09B | 4.71% | $6.40B | 150.24 | $21.57B | 12.87 | ||
| TECH | BIO-TECHNE CORP | $72.53 | $16.01 | 352.91% | 61.99x | 34.91x | 9.31x | 5.40x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.40B | 32.79 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.34 | $29.60 | 32.92% | 12.53x | 9.44x | 2.37x | 2.29x | 0.75x | $354.90M | 15.57% | $999.24M | 17.25 | $1.90B | 6.77 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $742.12 | $420.83 | 76.35% | 17.69x | 13.23x | 4.91x | 2.41x | 0.94x | $3.76B | 4.93% | $31.71B | 308.48 | $76.66B | 13.33 | ||
| VCYT | VERACYTE INC | $43.16 | $11.53 | 274.21% | 29.97x | 22.19x | 6.14x | 2.50x | 2.52x | $165.99M | 4.81% | $1.39B | 17.36 | $3.21B | 22.97 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.17 | $1.37 | -14.29% | 8.36x | -2.64x | 1.44x | 1.54x | 0.47x | $19.58M | 28.89% | $44.20M | 0.76 | $19.40M | 2.54 | ||
| INCY | INCYTE CORP | $113.44 | $57.93 | 95.81% | 13.97x | 32.00x | 3.91x | 3.62x | 1.57x | $1.92B | 8.45% | $6.34B | 31.66 | $19.04B | 9.21 |